Zur Kurzanzeige

2019-12-27Zeitschriftenartikel DOI: 10.25646/6554
Low prevalence of Borna disease virus 1 (BoDV-1) IgG antibodies in humans from areas endemic for animal Borna disease of Southern Germany
dc.contributor.authorTappe, Dennis
dc.contributor.authorFrank, Christina
dc.contributor.authorOffergeld, Ruth
dc.contributor.authorWagner-Wiening, Christiane
dc.contributor.authorStark, Klaus
dc.contributor.authorRubbenstroth, Dennis
dc.contributor.authorGiese, Sebastian
dc.contributor.authorLattwein, Erik
dc.contributor.authorSchwemmle, Martin
dc.contributor.authorSchmidt-Chanasit, Jonas
dc.contributor.authorWilking, Hendrik
dc.date.accessioned2020-03-18T08:00:37Z
dc.date.available2020-03-18T08:00:37Z
dc.date.issued2019-12-27none
dc.identifier.other10.1038/s41598-019-56839-4
dc.identifier.urihttp://edoc.rki.de/176904/6522
dc.description.abstractBorna disease virus-1 (BoDV-1) was recently discovered as cause of severe and often fatal encephalitis in humans. BoDV-1 is known to cause neurological disease in horses and sheep mainly in South and Central Germany. The virus is maintained in bicolored white-toothed shrews (Crocidura leucodon). The incidence of infection and risk factors in humans are completely unresolved. Veterinarians may be disproportionally BoDV-1-exposed through contact to animals not recognized to be BoDV-1 infected. We conducted three serosurveys predominantly in endemic areas of South Germany for the presence of BoDV-1-reactive antibodies. Anonymized residual samples from two serosurveys of veterinarians (n = 736) with interview data on exposures and one serosurvey among blood donors (n = 373) were screened with an indirect immunofluorescence antibody test, followed by a newly developed immunoblot as confirmatory assay. One serum from a 55–59-year-old veterinarian who worked in an animal practice and as a meat inspector but none from blood donors tested positive by the screening and confirmatory assays. We show that seropositive individuals are rare even in areas with highest zoonotic risk and in a group with potentially elevated exposure risk. In light of the low seroprevalence demonstrated here, the high case-fatality rate in clinically observed human BoDV-1 infections is even more impressive.eng
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.rights(CC BY 3.0 DE) Namensnennung 3.0 Deutschlandger
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/de/
dc.subjectRisk factorseng
dc.subjectViral epidemiologyeng
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleLow prevalence of Borna disease virus 1 (BoDV-1) IgG antibodies in humans from areas endemic for animal Borna disease of Southern Germanynone
dc.typearticle
dc.identifier.urnurn:nbn:de:kobv:0257-176904/6522-0
dc.identifier.doihttp://dx.doi.org/10.25646/6554
dc.type.versionpublishedVersionnone
local.edoc.container-titleScientific Reportsnone
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttps://www.nature.com/articles/s41598-019-56839-4#Abs1none
local.edoc.container-publisher-nameSpringer Naturenone
local.edoc.container-volume9none
local.edoc.container-issue20154none
local.edoc.container-year2019none
local.edoc.container-firstpage1none
local.edoc.container-lastpage6none
local.edoc.rki-departmentInfektionsepidemiologienone
dc.description.versionPeer Reviewednone

Zur Kurzanzeige